Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Pathos

Explore full profile

Reimagining drug discovery and development through the lens of technology, with an AI intelligence platform

Chicago, United StatesFounded 2022Biotech & Life Sciences
Valuation $1–2.5B Last recorded · 2025
Headcount <100 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Pathos and the history behind them.

About Pathos

Pathos is a biotechnology company that operates at the intersection of artificial intelligence and oncology. The company's core mission is to accelerate the development of cancer drugs by leveraging a sophisticated platform that integrates vast amounts of oncology data, including genomic information.

Read full description

Pathos utilizes advanced AI and machine learning algorithms to analyze this complex data, aiming to re-engineer the drug development process. This data-driven approach allows the company to identify and validate novel therapeutic targets and biomarkers, ultimately leading to more effective and personalized cancer treatments.

The company's business model is centered on collaborating with pharmaceutical and biotechnology partners to advance their oncology pipelines. By providing its AI-powered platform and insights, Pathos helps its clients to de-risk drug development, reduce timelines, and increase the probability of success for new cancer therapies. The company serves a clientele of researchers, drug developers, and clinicians in the oncology space.

Source: Dealroom company data

At a glance

Founded
2022
Headquarters
Chicago, United States
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tier

Latest news

Press, funding announcements and product moves mentioning Pathos.

See all news

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later4 investors entered at this stage

  • NEA
  • Lightbank
  • Revolution
  • Builders VC
Employees mapped 98 incl. 4 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 9 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown
Web traffic by country
7.4K monthly visits
across markets
🇺🇸 United States82.4%
🇮🇳 India16.2%
🇯🇵 Japan0%
Top 3 markets shown

Patents

Estimated portfolio value
$39k

1 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Pathos on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Pathos on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.